Home/Opna Bio/Stuart Barlow, MBA, CPA
SB

Stuart Barlow, MBA, CPA

Chief Accounting Officer

Opna Bio

Therapeutic Areas

Opna Bio Pipeline

DrugIndicationPhase
Zavabresib (OPN-2853)MyelofibrosisPhase 1
OPN-6602Multiple MyelomaPhase 1
Multi-functional DegradersMyeloma and LymphomaPreclinical
OPN-FMRPSolid TumorsResearch